Which cardiac potassium channel subtype is the preferable target for suppression of ventricular arrhythmias?

Pharmacology and Therapeutics

Volumn 69, Issue 3, 1996, Pages 199-217

  Rees, Siân ^a   Curtis, Michael J ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

arrhythmias; ATP dependent channel; delayed rectifier; inward rectifier; ischaemia; potassium channels; transient outward current

Indexed keywords

4 AMINOPYRIDINE; 5 HYDROXYDECANOIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; CLOFILIUM; CROMAKALIM; DOFETILIDE; GLIBENCLAMIDE; N [4 [1 HYDROXY 2 [4 (4 PYRIDYL) 1 PIPERAZINYL]ETHYL]PHENYL]METHANESULFONAMIDE; PINACIDIL; POTASSIUM; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; SEMATILIDE; SOTALOL; TACRINE; TEDISAMIL; TERIKALANT; UNCLASSIFIED DRUG;

DRUG MECHANISM; DRUG USE; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HEART VENTRICLE ARRHYTHMIA; HUMAN; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; TORSADE DES POINTES;

EID: 0029889345     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/0163-7258(95)02063-2     Document Type: Review

References (269)

1. K blocking drugs, UK-68,798 (dofetilide) and E-4031. Cardiovasc. Res. 27: 861-867.
2. + channel inhibitor, glibenclamide, to reduce reperfusion-induced or ischaemic arrhythmias in rat hearts. Br. J. Pharmacol. 100: 438P.
3. Adams, D., Lad, N., MacKenzie, I. and Manning, A. S. (1990b) Reduction of ischaemia-induced arrhythmias in the guinea-pig heart by lignocaine but not by class III antiarrhythmics. J. Mol. Cell. Cardiol. 22 (Suppl. III): S69.
4. Adgey, A. A. J. (1982) Sudden death, ventricular fibrillation, ventricular defibrillation - historical review and recent advances. In: Acute Phase of Ischemic Heart Disease and Myocardial Infarction, pp. 1-21, Adgey, A. A. J. (ed.) Martinus Nijhoff, The Hague.
5. Adgey, A. A. J., Nelson, P. G., Scott, M. E., Gedes, J. S., Allen, J. D. and Zaidi, S. A. (1969) Management of ventricular fibrillation outside hospital. Lancet ii: 1169-1171.
6. Aksnes, G. (1992) Why do ischemic and hypoxic myocardium lose potassium? J. Mol. Cell. Cardiol. 24: 323-331.
7. A Multicentre International Study (1975) Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. Br. Med. J. 3: 735-740.
8. Andersen, H. R., Wiggers, H. S., Knudsen, L., Simonsen, I., Thomsen, P. E. B. and Christiansen, N. (1992) Dofetilide suppresses ventricular fibrillation during acute myocardial ischaemia. A randomized study in pigs. Circulation 86 (Suppl. I): I-301.
9. Argentieri, T. M. (1992) Sematilide. Cardiovasc. Drug Rev. 10: 182-198.
10. Bargheer, K., Bode, F., Kuster, L. J., Sachse, A., Klein, H. U., Trappe, H. J. and Lichtlen, P. R. (1992) Effect of intravenous tedisamil on human monophasic action potentials and refractory period. Circulation 86: I-265.
11. Baskin, E. P., Serik, C. M., Wallace, A. A., Brookes, L. M., Selnick, H. G., Claremon, D. A. and Lynch, J. J. (1991) Effects of new and potent methane-sulfonanilide class III antiarrhythmic agents on myocardial refractoriness and contractility in isolated cardiac muscle. J. Cardiovasc. Pharmacol. 18: 406-414.
12. Baum, R. S., Alvarez, H. and Cobb, L. A. (1974) Survival after resuscitation from out-of-hospital ventricular fibrillation. Circulation 50: 1231-1235.
13. Beatch, G. N. (1995) Q-T interval prolongation and drug-induced torsade de pointes in rabbits. J. Mol. Cell. Cardiol. 27: A15.
14. Beatch, G. N., MacLeod, B. A., Abraham, S. and Walker, M. J. A. (1990) The in vivo electrophysiological actions of the new potassium channel blockers, tedisamil and UK68,798. Proc. West. Pharmacol. Soc. 33: 5-8.
15. + current blocker. Br. J. Pharmacol. 102: 13-18.
16. ATP modulators lemakalim and glibenclamide on the susceptibility of the rabbit isolated ischemic heart to fibrillation induced by programmed electrical stimulation (PES). Fundam. Clin. Pharmacol. 5: 452.
17. Ben-David, J. and Zipes, D. P. (1993) Torsades de pointes and proarrhythmia. Lancet 341: 1578-1582.
18. Bénitah, J.-P., Bailly, P., Da Ponte, J.-P., De Riberolles, C. and Lorente, P. (1992) Outward currents in isolated septal myocytes from human hypertrophied left ventricles. Circulation 86: 1-697.
19. Beregi, J., Escande, D., Coudray, N., Mery, P., Mestre, M., Chemla, D. and Lecarpentier, Y. (1992) Positive inotropic effects of RP62719, a new pure class III antiarrhythmic agent, on guinea pig myocardium. J. Pharmacol. Exp. Ther. 263: 1369-1376.
20. Bernier, M., Curtis, M. J. and Hearse, D. J. (1989) Ischaemia-induced and reperfusion-induced arrhythmias: the importance of heart rate. Am. J. Physiol. 256: H21-H31.
21. Billman, G. E. (1994) Role of ATP sensitive potassium channel in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischaemia. Cardiovasc. Res. 28: 762-769.
22. Billman, G. E., Avendano, C. E., Halliwill, J. R. and Burroughs, J. M. (1993) The effects of the ATP-dependent potassium channel antagonist, glyburide, on coronary blood flow and susceptibility to ventricular fibrillation in unanesthetised dogs. J. Cardiovasc. Pharmacol. 21: 197-204.
23. Black, S. C. and Lucchesi, B. R. (1994) Potassium channel openers are likely to be proarrhythmic in the diseased human heart. Cardiovasc. Res. 28: 923-924.
24. Black, S. C., Chi, L., Mu, D. and Lucchesi, B. R. (1991) The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent. J. Pharmacol. Exp. Ther. 258: 416-423.
25. Bolli, R., Fisher, D. J. and Entman, M. L. (1986) Factors that determine the occurrence of arrhythmias during acute myocardial ischemia. Am. Heart J. 111: 261-270.
26. Brachmann, J., Schmitt, C., Waldecker, B., Schols, W., Beyer, T., Offner, B., Navarrete, L., Schweizer, M. and Kubler, W. (1991) Acute and chronic efficacy of sotalol for treatment of ventricular arrhythmias. J. Am. Coll. Cardiol. 17: 137A.
27. Bril, A., Laville, M. and Gout, B. (1992) Effects of glibenclamide on ventricular arrhythmias and cardiac function in ischemia and reperfusion in isolated rat heart. Cardiovasc. Res. 26: 1069-1076.
28. British Medical Association and Royal Pharmaceutical Society of Great Britain (1993) Ventricular arrhythmias. British National Formulary 25: 73-74.
29. Brooks, R. R., Miller, K. E., Carpenter, J. F. and Jones, S. M. (1989) Broad sensitivity of rodent arrhythmia models to class I, II, III, and IV antiarrhythmic agents. Proc. Soc. Exp. Biol. Med. 191: 201-209.
30. + channels. Annu. Rev. Biophys. Biomol. Struct. 22: 173-198.
31. Burkart, F., Pfisterer, M., Kiowski, W., Burckhardt, D. and Follath, F. (1989) Improved survival of patients with sympathomatic ventricular arrhythmias after myocardial infarction with amiodarone: a randomised controlled trial. Circulation 80: 11-119.
32. Busch, A. E., Malloy, K. J., Varnum, M. D., Adelman, J. P., North, R. A. and Maylie, J. (1993) A slowly activating potassium current IKs is the target for the class III antiarrhythmic drug NE-10064. Circulation 88 (Suppl): I-231.
33. Cacciapuoti, F., Spiezia, R., Bianchi, U., Lama, D., D'Avino, M. and Varrichio, M. (1991) Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in noninsulin-dependent diabetes mellitus. Am. J. Cardiol. 67: 843-847.
34. Camm, A. J. (1984) Cardiac electrophysiology of four new antiarrhythmic drugs, encainide, flecainide, lorcainide and tocainide. Eur. Heart J. 5 (Suppl.): 75-79.
35. Carlsson, L., Almgren, O. and Duker, G. (1990) QTU prolongation and torsades de pointes induced by putative Class III antiarrhythmic agents in the rabbit: etiology and interventions. J. Cardiovasc. Pharmacol. 16: 276-285.
36. Carlsson, L., Abrahamsson, C., Almgren, O., Lundberg, C. and Duker, G. (1991) Prolonged action potential duration and positive inotropy induced by the novel class III antiarrhythmic agent H234/09 (Almokalant) in isolated human ventricular muscle. J. Cardiovasc. Pharmacol. 18: 882-887.
37. Carmeliet, E. (1982) Induction and removal of inward-going rectification in sheep cardiac purkinje fibres. J. Physiol. 327: 285-308.
38. Carmeliet, E. (1985) Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and purkinje fibers. J. Pharmacol. Exp. Ther. 232: 817-825.
39. + current in cardiac myocytes. J. Mol. Cell. Cardiol. 23 (Suppl. V): S8.
40. + current in cardiac myocytes by dofetilide. J. Pharmacol. Exp. Ther. 262: 809-817.
41. + current by almokalant in rabbit ventricular myocytes. Circ. Res. 73: 857-868.
42. Castle, N. A. (1991) Two distinct potassium currents are activated by depolarization in adult rat ventricular myocytes. Br. J. Pharmacol. 105: 113P.
43. Ceremuzynski, L., Kleczar, E., Krzeminska-Pakula, M., Kuch, J., Nartowicz, E., Smielak-Korombel, J., Dyduszynski, A., Maciejewicz, J., Zaleska, T. and Budaj, A. (1991) Low dose amiodarone decreases mortality after myocardial infarction: multicenter, double blind, placebo controlled study. Circulation 84: II-347.
44. Chen, F., Wetzel, G. T., Friedman, W. F. and Klitzner, T. S. (1991) Single-channel recording of inwardly rectifying potassium currents in developing myocardium. J. Mol. Cell. Cardiol. 23: 259-267.
45. Chi, L., Mu, D., Driscoll, E. M. and Lucchesi, B. R. (1990) Antiarrhythmic and electrophysiologic actions of CK-3579 and sematilide in a conscious canine model of sudden coronary death. J. Cardiovasc. Pharmacol. 16: 312-324.
46. Chi, L., Mu, D. and Lucchesi, B. R. (1991) Electrophysiology and antiarrhythmic actions of E-4031 in the experimental animal model of sudden coronary death. J. Cardiovasc. Pharmacol. 17: 285-295.
47. Chi, L., Black, S. C., Kuo, P. I., Fagbemi, S. O. and Lucchesi, B. R. (1993) Actions of pinacidil at a reduced potassium concentration: a direct cardiac effect possibly involving the ATP-dependent potassium channel. J. Cardiovasc. Pharmacol. 21: 179-190.
48. Cobbe, S. M. (1988) Modification of class III antiarrhythmic activity in abnormal myocardium. Cardiovasc. Res. 22: 847-854.
49. Cobbe, S. M., Manley, B. S. and Alexopoulos, D. (1985) Interaction of the effects of hypoxia, substrate depletion, acidosis and hyperkalaemia on the class III antiarrhythmic properties of sotalol. Cardiovasc. Res. 19: 668-673.
50. Coetzee, W. (1992) Regulation of ATP sensitive potassium channel of isolated guinea pig ventricular myocytes by sarcolemmal monocarboxylate transport. Cardiovasc. Res. 26: 1077-1086.
51. Colatsky, T. J. (1992) Potassium channel blockers: synthetic agents and their antiarrhythmic potential. In: Potassium Channel Modulators, pp. 304-340, Weston, A. H. and Hamilton, T. C. (eds.) Blackwell Scientific Publications, Oxford.
52. Colatsky, T. J., Follmer, C. H. and Starmer, C. F. (1990) Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation 82: 2235-2241.
53. + channels protect the myocardium against ischemia/reperfusion damage. Circ. Res. 69: 571-581.
54. Cook, G. A. (1987) The hypoglycaemic sulfonylureas glyburide and tolbutamide inhibit fatty acid oxidation by inhibiting carnitine palmitoyl-transferase. J. Biol. Chem. 262: 4968-4972.
55. Culling, W., Penny, W. J. and Sheridan, D. J. (1984) Effects of sotalol on arrhythmias and electrophysiology during myocardial ischaemia and reperfusion. Cardiovasc. Res. 18: 397-404.
56. Curry, P., Fitchett, D., Stubbs, W. and Krikler, D. (1976) Ventricular arrhythmias and hypokalaemia. Lancet i: 231-233.
57. Curtis, M. J. (1991) Torsades de pointes: arrhythmia, syndrome, or chimera? A perspective in the light of the Lambeth Conventions. Cardiovasc. Drugs Ther. 5: 191-200.
58. Curtis, M. J. (1994) Chemical defibrillation in acute myocardial ischaemia: a hypothesis. J. Basic Clin. Physiol. Pharmacol. 5: 1-17.
59. Curtis, M. J., Pugsley, M. K. and Walker, M. J. A. (1993) Endogenous chemical mediators of ventricular arrhythmias in ischaemic heart disease. Cardiovasc. Res. 27: 703-719.
60. D'Alonzo, A. J. and Grover, G. J. (1994) Potassium channel openers are unlikely to be proarrhythmic in the diseased human heart. Cardiovasc. Res. 28: 924-925.
61. D'Alonzo, A. J., Darbenzio, R. B., Parham, C. S. and Grover, G. J. (1992) Effects of intracoronary cromakalim on postischaemic contractile function and action potential duration. Cardiovasc. Res. 26: 1046-1053.
62. D'Alonzo, A. J., Hess, T. A., Darbenzio, R. B. and Sewtet, J. C. (1993) Effects of intracoronary cromakalim, pinacidil, or diltiazem on cesium chloride-induced arrhythmias in anesthetised dogs under conditions of controlled coronary blood flow. Cardiovasc. Res. 27: 677-683.
63. D'Alonzo, A. J., Darbenzio, R. B., Hess, T. A., Sewter, J. C., Sleph, P. G. and Grover, G. J. (1994) Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia. Cardiovasc. Res. 28: 881-887.
64. Dalrymple, H. W., Butler, P., Dodd, M. G. and Sutton, M. R. (1989) Electrocardiographic and haemodynamic effects in conscious dogs of UK68-798, a new class III antiarrhythmic agent. Eur. Heart J. 10 (Suppl.): 395.
65. Davies, M. J. and Thomas, A. (1984) Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N. Engl. J. Med. 310: 1137-1140.
66. Dessertenne, F. (1966) La tachycardie ventriculaire a deux foyers opposes variables. Arch. Mal. Coeur Vaiss. 59: 263-272.
67. Dhein, S., Muller, A., Gerwin, R. and Klaus, W. (1993) Comparative study on the proarrhythmic effects of some antiarrhythmic agents. Circulation 87: 617-630.
68. Di Diego, J. M., Sicouri, S., Litovsky, S. H. and Antzelevitch, C. (1991) Two components of the transient outward in canine ventricular epicardium: right vs. left. Circulation 84: II-179.
69. Doyle, J. T. (1975) Profile of risk of sudden death in apparently healthy people. Circulation 51/52 (Suppl. III): 176-179.
70. Duff, H. J., Brown, E. and Li, W. (1991) H234 a newer class III agent: electrophysiologic effects in vivo and in vitro. J. Am. Coll. Cardiol. 17: 136A.
71. + currents in mammalian cardiac and atrial cells. J. Pharmacol. Exp. Ther. 254: 560-569.
72. Echt, D. S., Lee, J. T., Murray, K. T., Vorperian, V., Borganelli, S. M., Crawford, D. M. and Roden, D. M. (1991) A randomized, double-blind, placebo-controlled dose-ranging study of intravenous UK68,798 (dofetilide) in patients with inducible sustained ventricular tachyarrhythmias. Circulation 84 (Suppl. II): II-714.
73. Elonen, E., Neuvonen, P. J., Tarssanen, L. and Kala, R. (1979) Sotalol intoxication with prolonged Q-T interval and severe tachyarrhythmias. Br. Med. J. 5 May, 1184.
74. K1 blockade controversy: the right tool in the right species. Cardiovasc. Res. 28: 1118.
75. + current in heart cells. Circulation 80 (Suppl. II): 607.
76. + current acting as pure class III antiarrhythmic agents. J. Cardiovasc. Pharmacol. 20 (Suppl. 2): S106-S113.
77. Escande, D., Le Guern, S., Laville, M., Courteix, J. and Pradier, L. (1994) Membrane current changes responsible for the class III antiarrhythmic properties of RP58866 and its active enantiomer, RP62719. In: Electropharmacological Control of Cardiac Arrhythmias, pp. 597-609, Singh, B. N., Wellens, H. J. J. and Hiraoka, M. (eds.) Futura Publishing Co., New York.
78. Fagbemi, S. O., Black, S. C., Chi, L., Cunningham, M. R. and Lucchesi, B. R. (1991) Pinacidil- and phorbol 12,13-dibutyrate-induced ventricular fibrillation: antagonism by glybenclamide. Circulation 84: II-502.
79. Fagbemi, S. O., Chi, L. and Lucchesi, B. R. (1993) Antifibrillatory and profibrillatory actions of selected class 1 antiarrhythmic agents. J. Cardiovasc. Pharmacol. 21: 709-719.
80. + channels in adult rat ventricular cells. J. Mol. Cell. Cardiol. 24 (Suppl. VI): S40.
81. + channels in rabbit ventriular myocytes. Circ. Res. 72: 715-722.
82. Fananapazir, L. and Cropp, A. (1992) Hemodynamic, electrophysiologic, and pharmacokinetic properties of intravenous dofetilide (UK 68,798), a novel class III antiarrhythmic drug. J. Am. Coll. Cardiol. 19 (Suppl. A): 131A.
83. Fedida, D. and Giles, W. R. (1991) Regional variations in action potentials and transient outward current in myocytes isolated from rabbit left ventricle. J. Physiol. 442: 191-209.
84. + channels in cardiac muscle. J. Pharmacol. Exp. Ther. 262: 71-79.
85. Fish, F. A., Prokash, C. and Roden, D. M. (1990) Suppression of repolarization-related arrhythmias in vitro and in vivo by low-dose potassium channel activators. Circulation 82: 1362-1369.
86. Fletcher, R. D. (1991) Sudden cardiac death after myocardial infarction. Drugs 41 (Suppl. 2): 1-8.
87. sK channel from neonatal rat heart and diethylstilbestrol-primed rat uterus. Proc. Natl. Acad. Sci. USA 87: 2975-2979.
88. Fozzard, H. A. and Hiroaka, M. (1973) The positive dynamic current and its inactivation properties in cardiac purkinje fibres. J. Physiol. 234: 569-586.
89. Frech, G. C., VanDongen, A. M. J., Schuster, G., Brown, A. M. and Joho, R. H. (1989) A novel potassium channel with delayed rectifier properties isolated from rat brain by expression cloning. Nature 340: 642-645.
90. Freeman, L. C., Kwok, W. M., Anumonwo, J. M. B. and Kass, R. S. (1992) Potassium channels in the heart: physiological function and neurohormonal regulation. In: Potassium Channel Modulators, pp. 181-203, Weston, A. H. and Hamilton, T. C. (eds.) Blackwell Scientific Publications, Oxford.
91. Garan, H., McComb, J. M. and Ruskin, J. N. (1988) Spontaneous and electrically induced ventricular arrhythmias during acute ischemia superimposed on 2 week old canine myocardial infarction. J. Am. Coll. Cardiol. 11: 603-611.
92. Gasser, R. N. A. and Vaughan-Jones, R. D. (1990) Mechanism of potassium efflux and action potential shortening during ischaemia in isolated mammalian cardiac muscle. J. Physiol. 431: 713-741.
93. Gibson, J. K. and Kersten, J. A. (1990) In vivo assessment of class III agents and their antiarrhythmic activity. Drug Dev. Res. 19: 129-140.
94. Giles, W. R. and Van Ginneken, A. C. G. (1985) A transient outward current in isolated cells from the crista terminalis of rabbit heart. J. Physiol. 368: 243-264.
95. Goldstein, S., Landis, J. R., Leighton, R., Ritter, G., Vasu, C. M., Lantis, A. and Serokman, R. (1981) Characteristics of the resuscitated out-of-hospital cardiac arrest victim with coronary heart disease. Circulation 64: 977-984.
96. Goupil, N. and Lenfant, J. (1976) The effects of amiodarone on the sinus node activity of the rabbit heart. Eur. J. Pharmacol. 39: 23-31.
97. Greene, T. O. and Spodick, D. H. (1992) Recognition and management of torsades de pointes. Heart Dis. Stroke 1: 383-390.
98. Grover, G. J., McCullough, J. R., Henry, D. E., Lee Conder, M. and Sleph, P. G. (1989) Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with potassium channel blocker glyburide. J. Pharmacol. Exp. Ther. 251: 98-104.
99. Grover, G. J., Dzwonczyk, S., Parham, C. S. and Sleph, P. G. (1990) The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetised dogs. Cardiovasc. Drugs Ther. 4: 465-474.
100. Gwilt, M., Higgins, A. J. and Williams, R. C. (1986) The use of rat and guinea pig cardiac action potentials to distinguish subclasses of class III antiarrhythmic drugs. Br. J. Pharmacol. 88 (Suppl.): 290P.
101. Gwilt, M., Dalrymple, H. W., Blackburn, K. J., Burges, R. A. and Higgins, A. J. (1988) UK66914 - a novel class III antiarrhythmic agent which blocks potassium channels. Circulation 78 (Suppl. II): 150.
102. Gwilt, M., Arrowsmith, J. E., Blackburn, K. J., Burges, R. A., Cross, P. E., Dalrymple, H. W. and Higgins, A. J. (1990) UK-68,798: a novel, potent and highly selective Class III antiarrhythmic agent which blocks potassium channels in cardiac cells. J. Pharmacol. Exp. Ther. 256: 318-324.
103. Gwilt, M., Dalrymple, H. W., Burges, R. A., Blackburn, K. J., Dickinson, R. P., Cross, P. E. and Higgins, A. J. (1991) Electrophysiologic properties of UK66914, a novel class III antiarrhythmic agent. J. Cardiovasc. Pharmacol. 17: 376-385.
104. Gwilt, M., Blackburn, K. J., Burges, R. A., Higgins, A. J., Milne, A. A. and Solca, A. M. (1992a) Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogs. Eur. J. Pharmacol. 215: 137-144.
105. - loss in a model of ischaemia in perfused guinea-pig hearts in vitro. Eur. J. Pharmacol. 220: 231-236.
106. Hansteen, V., Mønichen, E., Lorentsen, E., Andersen, A., Strøm, O., Søiland, K., Dyrbekk, D., Refsum, A.-M., Tromsdal, A., Knudsen, K., Eika, C., Bakken, J., Smith, P. and Hoff, P. I. (1982) One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Br. Med. J. 284: 155-161.
107. Hearse, D. J. (1995) Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection? Cardiovasc. Res. 30: 1-17.
108. Hicks, M. N. and Cobbe, S. M. (1990) Attenuation of the rise in extracellular potassium concentration during myocardial ischaemia by d.Isotalol and d-sotalol. Cardiovasc. Res. 24: 404-410.
109. Hicks, M. N. and Cobbe, S. M. (1991) Effect of glibenclamide on extracellular potassium accumulation and the electrophysiological changes during myocardial ischemia in the arterially perfused interventricular septum of rabbit. Cardiovasc. Res. 25: 407-413.
110. + activity in swine. Circulation 61: 768-778.
111. Hiraoka, M. and Kawano, S. (1989) Calcium-sensitive and insensitive transient outward current in rabbit ventricular myocytes. J. Physiol. 410: 187-212.
112. + increase and noradrenaline release as possible cause of early arrhythmias following acute coronary artery occlusion in pigs. J. Mol. Cell. Cardiol. 12: 579-593.
113. Ho, K., Nichols, C. G., Lederer, W. J., Lytton, J., Vassilev, P. M., Kanazirska, M. V. and Hebert, S. C. (1993) Cloning and expression of an inwardly rectifying ATP-regulated potassium channel. Nature 362: 31-38.
114. + release and arrhythmias in isolated rat hearts during low flow ischemia. Cardiovasc. Drugs Ther. 5: 403.
115. Hondeghem, L. M. and Snyders, D. J. (1990) Class III antiarrhythmic agents have a lot of potential but a long way to go: reduced effectiveness and dangers of reverse use dependence. Circulation 81: 686-690.
116. Horie, M., Tominaga, M., Matsumori, A. and Sasayama, S. (1993) Modulation of cardiac catecholamine-activated chloride current by sulfonylurea. J. Mol. Cell. Cardiol. 25 (Suppl. II): S3.
117. Horowitz, L. N. (1988) Proarrhythmia - taking the bad with the good. N. Eng. J. Med. 319: 304-305.
118. K1 blockade proarrhythmic or antiarrhythmic? Cardiovasc. Res. 28: 1120-1121.
119. 2+-induced automaticity. Am. J. Physiol. 252: H325-H333.
120. Jan, L. Y. and Jan, Y. N. (1994) Potassium channels and their evolving gates. Nature 371: 119-122.
121. Janse, M. J. and Coronel, R. (1992) The current of injury in acute myocardial ischaemia. In: Myocardial Response to Acute Injury, pp. 97-109, Parratt, J. R. (ed.) Macmillan Press, New York.
122. Janse, M. J., van Capelle, F. J. L., Morsink, H., Kleber, A. G., Wilms-Schopman, F., Cardinal, R., D'Alnoncourt, C. N. and Durrer, D. (1980) Flow of 'injury' current and patterns of excitation during early ventricular arrhythmias in acute regional myocardial ischemia in isolated porcine and canine hearts. Evidence for two different arrhythmogenic mechanisms. Circ. Res. 47: 151-165.
123. Johnston, K. M., MacLeod, B. A. and Walker, M. J. A. (1983) Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics. Can. J. Physiol. Pharmacol. 61: 1340-1353.
124. + currents in rat ventricular myocytes. J. Memb. Biol. 94: 19-35.
125. Josephson, I. R., Sanchez-Chapula, J. and Brown, A. M. (1984) Early outward current in rat single ventricular cells. Circ. Res. 54: 157-162.
126. Julian, D. G., Prescott, R. J., Jackson, F. S. and Szekely, P. (1982) Controlled trial sotalol for one year after myocardial infarction. Lancet ii: 1142-1147.
127. + current by dofetilide. Circ. Res. 72: 75-83.
128. Kameyama, M., Kiyosue, T. and Soejima, M. (1983) Single channel analysis of the inward rectifier K current in the rabbit ventricular cells. Jpn. J. Physiol. 33: 1039-1056.
129. + loss and arrhythmias in rat hearts: effect of glibenclamide, a sulfonylurea. Circ. Res. 66: 478-485.
130. Kaumann, A. J. and Aramendia, P. (1968) Prevention of ventricular fibrillation induced by coronary ligation. J. Pharmacol. Exp. Ther. 164: 326-332.
131. Kawano, S. and Hiraoka, M. (1991) Transient outward currents and action potential alterations in rabbit ventricular myocytes. J. Mol. Cell. Cardiol. 23: 681-693.
132. Kempsford, R. D. and Hawgood, A. (1989) Assessment of the antiarrhythmic activity of nicorandil during myocardial ischaemia and reperfusion. Eur. J. Pharmacol. 163: 61-68.
133. Kenyon, J. L. and Gibbons, W. R. (1979) Influence of chloride, potassium, and tetraethylammonium on the early outward current of sheep cardiac purkinje fibers. J. Gen. Physiol. 73: 117-138.
134. Kenyon, J. L. and Sutko, J. L. (1987) Calcium- and voltage-activated plateau currents of cardiac purkinje fibers. J. Gen. Physiol. 89: 921-958.
135. Kim, S. G., Felder, S. D., Figura, I., Johnston, D. R., Mercando, A. D. and Fisher, J. D. (1987) Prognostic value of the changes in the mode of ventricular tachycardia induction during therapy with amiodarone or amiodarone and a class IA antiarrhythmic agent. Am. J. Cardiol. 59: 1314-1318.
136. Kleber, A. G. (1983) Resting membrane potential, extracellular potassium activity, and intracellular sodium activity during acute global ischemia in isolated guinea pig hearts. Circ. Res. 52: 442-450.
137. Kleber, A. G. (1984) Extracellular potassium accumulation in acute myocardial ischemia. J. Mol. Cell. Cardiol. 16: 389-394.
138. K1 blockade controversy. Cardiovasc. Res. 28: 720.
139. Kleber, A. G., Janse, M. J., van Capelle, F. J. L. and Durrer, D. (1978) Mechanism and time course of S-T and T-Q segment changes during acute regional myocardial ischemia in the pig heart determined by extracellular and intracellular recordings. Circ. Res. 42: 603-613.
140. Knilans, T. K., Lathrop, D. A., Nanasi, P. P., Schwartz, A. and Varro, A. (1991) Rate and concentration-dependent effects of UK-68,798, a potent new class III antiarrhythmic, on canine Purkinje fibre action potential duration. Br. J. Pharmacol. 103: 1568-1572.
141. Kopia, G. A., Eller, B. T., Patterson, E., Shea, M. J. and Lucchesi, B. R. (1985) Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models. Eur. J. Pharmacol. 116: 49-61.
142. + channel behaviour in isolated cardiac myocytes from patients with dilated cardiomyopathy. Circulation 88 (Suppl.): 1-232.
143. Kubo, Y., Baldwin, T. J., Jan, Y. N. and Jan, L. Y. (1993) Primary structure and functional expression of a mouse inward rectifier potassium channel. Nature 362: 127-133.
144. Kuck, K. H., Kunze, K. P., Roewer, N. and Bleifield, W. (1984) Sotalol-induced torsade de pointes. Am. Heart J. 107: 179-180.
145. Lad, N. and MacKenzie, I. (1991) Limited effect of class III agents against acute ischaemic arrhythmias in anaesthetised cats. J. Mol. Cell. Cardiol. 23 (Suppl. V): S38.
146. + channels in isolated membrane patches. J. Physiol. 419: 193-211.
147. Lesh, M. D., Siu, A. H., Pederson, D. N., Eggleston, R., Gonzales, R. and Scheinman, M. M. (1991) Electrophysiologic-guided therapy with sotalol for inducible ventricular tachycardia (VT): long-term outcome. Circulation 84: 11-125.
148. Liberthson, R. R., Nagel, E. L., Hirschman, J. C., Nussenfeld, S. R., Blackbourne, B. D. and Davis, J. H. (1974) Pathophysiologic observations in prehospital ventricular fibrillation and sudden cardiac death. Circulation XLIX: 790-798.
149. Litovsky, S. H. and Antzelevitch, C. (1988) Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ. Res. 62: 116-126.
150. Liu, D., Gintant, G. A. and Antzelevitch, C. (1993) Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle. Circ. Res. 72: 671-687.
151. Lucchesi, B. R. (1984) Sudden coronary death: pharmacological interventions for the prevention of ventricular fibrillation. Trends Pharmacol. Sci. 5: 145-148.
152. Lynch, J. J., Coskey, L. A., Montgomery, D. G. and Lucchesi, B. R. (1985) Prevention of ventricular fibrillation by dextrorotatory sotalol in conscious canine model of sudden coronary death. Am. Heart J. 109: 949-958.
153. Lynch, J. J., Heaney, L. A., Wallace, A. A., Gehret, J. R., Selnick, H. G. and Stein, R. B. (1990) Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction. J. Cardiovasc. Pharmacol. 15: 764-775.
154. Manoach, M., Varon, D., Neuman, M. and Erez, M. (1988) A new group of defibrillatory drugs in the classification of antiarrhythmic agents. Int. J. Cardiol. 21: 211-217.
155. Martin, C. L. and Chinn, K. (1992) Contribution of delayed rectifier and inward rectifier to repolarization of the action potential: pharmacological separation. J. Cardiovasc. Pharmacol. 19: 830-837.
156. Mason, J. W., Hondeghem, L. M. and Katzung, B. G. (1983) Amiodarone blocks inactivated cardiac sodium channels. Pflügers Arch. 396: 79-81.
157. 2+. Nature 325: 156-159.
158. Maughan, D. W. (1976) Potassium movement during hyperpolarization of cardiac muscle. J. Memb. Biol. 28: 241-262.
159. McCullough, J. R., Normandin, D. E., Lee Conder, M., Sleph, P. G., Dzwonczyk, S. and Grover, G. J. (1991) Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ. Res. 69: 949-958.
160. McKibben, J. K., Pocock, W. A. and Barlow, J. B. (1984) Sotalol, hypokalaemia, syncope, and torsades de pointes. Br. Heart J. 51: 157-162.
161. Middlekauff, H. R., Stevenson, W. G., Stevenson, L. W. and Saxon, L. A. (1991) Antiarrhythmic drug therapy in 367 heart failure patients: class I drugs but not amiodarone are associated with increased sudden death risk. J. Am. Coll. Cardiol. 17: 92A.
162. Mitchell, M. R., Powell, T., Terrar, D. A. and Twist, V. W. (1984) Strontium, nifedipine and 4-aminopyridine modify the time course of the action potential in cells from rat ventricular muscle. Br. J. Pharmacol. 81: 551-556.
163. Miura, D. S. and Rosen, M. R. (1984) New directions in the development of antiarrhythmic drugs. J. Clin. Pharmacol. 24: 333-341.
164. Murakami, M., Furukawa, Y., Karasawa, Y., Ren, L., Takayama, S. and Chiba, S. (1992) Inhibition by glibenclamide of negative chronotropic and inotropic responses to pinacidil, acetylcholine, and adenosine in the isolated dog heart. J. Cardiovasc. Pharmacol. 19: 618-624.
165. Nabauer, M., Beuckelmann, D. J. and Erdmann, E. (1993) Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ. Res. 73: 386-394.
166. Niho, T., Notsu, T., Ishikawa, H., Funato, H., Yamasaki, F., Shinkawa, T., Nemursa, A. and Mizota, M. (1987) Study of mechanism and effects of sodium 5-hydroxydecanoate on experimental ventricular arrhythmias. Folia Pharmacol. Japn. 89: 155-167.
167. Nikolic, G., Bishop, R. L. and Singh, J. B. (1982) Sudden death recorded during holter monitoring. Circulation 66: 218-225.
168. Noble, D. (1984) The surprising heart: a review of recent progress in cardiac electrophysiology. J. Physiol. 353: 1-50.
169. Noble, D. and Tsien, R. W. (1969) Outward membrane currents activated in the plateau range of potentials in cardiac purkinje fibres. J. Physiol. 200: 205-231.
170. + channels in cardiac muscle. Nature 305: 147-148.
171. Nomoto, K.-I., Katoh, H., Sawada, K. and Shoji, T. (1989) Protective effects of a novel class 3 antiarrhythmic compound, E-4031, on life-threatening arrhythmias during early phase of ischemia in coronary ligated dogs. J. Mol. Cell. Cardiol. 21 (Suppl. II): S20.
172. + channels by sodium 5-hydroxydecanoate, a new antiarrhythmic agent, in isolated guinea pig heart cells. J. Mol. Cell. Cardiol. 21: S9.
173. + channel currents in guinea pig single ventricular myocytes. Eur. J. Pharmacol. 220: 35-41.
174. Nuss, H. B. and Marban, E. (1994) Electrophysiological properties of neonatal mouse cardiac myocytes in primary culture. J. Physiol. 479: 265-279.
175. Oliver, M. F. (1982) Sudden cardiac death-an overview. In: Early Arrhythmias Resulting From Myocardial Ischaemia, pp. 1-13, Pattatt, J. R. (ed.) Macmillan, New York.
176. K1 blockade controversy. Cardiovasc. Res. 28: 1119.
177. K1 blockade is unlikely to be a potentially useful antiarrhythmic mechanism. Cardiovasc. Res. 28: 421.
178. Osterrieder, W. (1987) 9-Amino-1,2,3,4-tetrahydroacridine (THA) is a potent blocker of cardiac potassium channels. Br. J. Pharmacol. 92: 521-525.
179. Padrini, R., Bova, S., Cargnelli, G., Piovan, D. and Ferrari, M. (1992) Effects of pinacidil on guinea pig isolated perfused heart with particular reference to the proarrhythmic effect. Br. J. Pharmacol. 105: 715-719.
180. Polster, P. and Broekhuysen, J. (1976) The adrenergic antagonism of amiodarone. Biochem. Pharmacol. 25: 131-134.
181. Pongs, O. (1992) Molecular biology of voltage-dependent potassium channels. Physiol. Rev. 72 (Suppl.): S69-S88.
182. Powell, T., Sturridge, M. F., Suvarna, S. K., Terrar, D. A. and Twist, V. W. (1981) Intact individual heart cells isolated from human ventricular tissue. Br. Med. J. 283: 1013-1015.
183. K blocker, UK66,914. Cardiovasc. Drug Rev. 10: 158-169.
184. K blockade as an antiarrhythmic mechanism: effects of UK66,914 on ischaemia- and reperfusion-induced arrhythmias in rat and rabbit. Br. J. Pharmacol. 108: 139-145.
185. Rees, S. A. and Curtis, M. J. (1993b) Tacrine inhibits ischaemia- and reperfusion-induced ventricular fibrillation and widens QT interval in rat. Cardiovasc. Res. 27: 453-458.
186. K1 blockade, a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit and primate. Circulation 87: 1979-1989.
187. Rees, S. A. and Curtis, M. J. (1994a) Lack of effect of clofilium on repolarisation in the rat isolated heart confirms that rat ventricle is devoid of functional delayed rectifier potassium current. Br. J. Pharmacol. 110: 120P.
188. K1 blockade is a potentially useful antiarrhythmic mechanism. Cardiovasc. Res. 28: 421.
189. + channel as a target for antifibrillatory intervention in acute myocardial ischaemia in rat. J. Cardiovasc. Pharmacol. 26: 280-288.
190. to blocker increases coronary flow independently of effects on heart rate, QT interval and ischaemia-induced ventricular fibrillation in rat. J. Cardiovasc. Pharmacol. 22: 343-349.
191. Rees, S. A., Vandenberg, J. I., Wright, A. R., Yoshida, A. and Powell, T. (1995) Cell swelling has differential effects on the rapid and slow components of delayed rectifier potassium current in guinea pig cardiac myocytes. J. Gen. Physiol. 106: 1151-1170.
192. Reiser, H. J. and Sullivan, M. E. (1986) Antiarrhythmic drug therapy: new drugs and changing concepts. Fed. Proc. 45: 2206-2212.
193. Rials, S. J., Wu, Y., Gabriel, A., Marinchak, R. A. and Kowey, P. R. (1991) Antifibrillatory effect of class III drug in chronic infarction. Circulation 84 (Suppl. II): II-505.
194. K1 in the myocardial response to hypoxia. Cardiovasc. Res. 25: 17-26.
195. Sakmann, B. and Trube, G. (1984) Conductance properties of single inwardly rectifying potassium channels in ventricular cells from guinea pig heart. J. Physiol. 347: 641-657.
196. Salata, J. J. and Wasserstrom, J. A. (1988) Effects of quinidine on action potentials and ionic currents in isolated ventricular myocytes. Circ. Res. 62: 324-337.
197. Sanguinetti, M. C. and Jurkiewicz, N. K. (1990) Two components of cardiac delayed rectifier current: differential sensitivity to block by class III antiarrhythmic agents. J. Gen. Physiol. 96: 195-215.
198. Kr potassium channel. Cell 81: 299-307.
199. Sano, T., Sugiyama, S., Taki, K., Hanaki, Y., Shimada, Y. and Ozawa, T. (1990) Effects of antiarrhythmic agents classified as class III group on ischaemia-induced myocardial damage in canine hearts. Br. J. Pharmacol. 99: 577-581.
200. Saviuc, P., Danel, V. and Dixmerias, F. (1993) Prolonged QT intervals and torsades de pointes following astemizole overdose. Clin. Toxicol. 31: 121-125.
201. + current by a novel class 3 antiarrhythmic agent, E-4031, in guinea pig single ventricular cells. J. Mol. Cell. Cardiol. 21 (Suppl. II): S20.
202. Schackow, T. E. and Ten Eick, R. E. (1994) Enhancement of ATP-sensitive potassium current in cat ventricular myocytes by beta-adrenoceptor stimulation. J. Physiol. 474: 131-145.
203. Sedgewick, M. J., Rasmussen, H. S. and Cobbe, S. M. (1990a) Effect of new class III antiarrhythmic agent (UK68798) on QT interval and heart rate. Br. Heart J. 64 (Suppl.): 66.
204. Sedgewick, M. J., Rasmussen, H. S. and Cobbe, S. M. (1990b) The effect of intravenous UK-68798, a novel class III antiarrhythmic agent, on electrocardiographic parameters in patients with ischemic heart disease. Eur. Heart J. 11 (Suppl.): 240.
205. Sedgewick, M. J., Rasmussen, H. S. and Cobbe, S. M. (1991) Electrophysiological effects of intravenous UK-68,798, a new class III antiarrhythmic agent. Clin. Sci. 80: 11P.
206. Selzer, A. and Wray, H. W. (1964) Quinidine syncope: paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias. Circulation XXX: 17-26.
207. Singh, B. N. (1989) When is QT prolongation antiarrhythmic and when is it proarrhythmic? Am. J. Cardiol. 63: 867-869.
208. Singh, B. N. (1991) When is drug therapy warranted to prevent sudden cardiac death? Drugs 41 (Suppl. 2): 24-46.
209. Singh, B. N. and Nademanee, K. (1985) Control of cardiac arrhythmias by selective lengthening of repolarization: theoretic considerations and clinical observations. Am. Heart J. 109: 421-430.
210. Singh, B. N. and Vaughan Williams, E. M. (1970a) The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br. J. Pharmacol. 39: 657-667.
211. Singh, B. N. and Vaughan Williams, E. M. (1970b) A third class of antiarrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br. J. Pharmacol. 39: 675-687.
212. + current activated by pinacidil. Circ. Res. 68: 1127-1137.
213. Spinelli, W., Parsons, R. W. and Colatsky, T. J. (1992) Effects of WAY-123,398, a new class III antiarrhythmic agent, on cardiac refractoriness and ventricular fibrillation threshold in anesthetised dogs: a comparison with UK-68798, E-4031 and dl-sotalol. J. Cardiovasc. Pharmacol. 20: 913-922.
214. K block and lack of reverse use dependence in cat ventricular myocytes. Cardiovasc. Res. 27: 1580-1591.
215. Steinbeck, G., Luderitz, B. and Andresen, D. (1989) Control of antiarrhythmic drug therapy by electrophysiologic testing. Eur. Heart J. 10 (Suppl. E): 61-65.
216. Steinberg, M. I. and Molloy, B. B. (1979) Clofilium - a new antifibrillatory agent that selectively increases cellular refractoriness. Life Sci. 25: 1397-1406.
217. Stone, V., Moon, W. and Shaw, F. H. (1961) Treatment of intractable pain with morphine and tetrahydroaminacrine. Br. Med. J. Feb. 18: 471-473.
218. Surawicz, B. and Knoebel, S. B. (1984) Long QT: good, bad or indifferent? J. Am. Coll. Cardiol. 4: 398-413.
219. Suttorp, M. J., Kingma, J. H., Peels, H. O. J., Koomen, E. M., Tijssen, J. G. P. and Hemel, N. M. (1991) Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. Am. J. Cardiol. 68: 1163-1169.
220. Taggart, P., Sutton, P. and Donaldson, R. (1985) d-Sotalol: a new potent class III anti-arrhythmic agent. Clin. Sci. 69: 631-636.
221. + channel function. News Physiol. Sci. 9: 169-173.
222. Tande, P. M. and Refsum, H. (1988) Class III antiarrhythmic action linked with positive inotropy: effects of d- and l-isomer of sotalol on isolated rat atria. Pharmacol. Toxicol. 62: 272-277.
223. k blocking drug, UK68.798: potent in guinea pig but no effect in rat myocardium. J. Cardiovasc. Pharmacol. 16: 401-410.
224. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology (1991) The Sicilian Gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmigenic mechanisms. Circulation 84: 1831-1851.
225. The Cardiac Arrhythmias Suppression Trial (CAST) Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N. Engl. J. Med. 321: 406-412.
226. The Coronary Prevention Group/British Heart Foundation Statistics Database (1992) Mortality. In: Coronary Heart Disease Statistics 1992, pp. 4-28, British Heart Foundation, London.
227. + outward current in isolated ventricular heart cells of the mouse. Pflügers Arch. 427: 547-549.
228. Thomsen, P., Bashir, Y., Kingma, J., Moller, M., Camm, A. and Butrous, G. (1992) Dofetilide in the treatment of sustained monomorphic ventricular tachycardia. Eur. Heart J. 13 (Suppl.): 304.
229. Toombs, C. F., Norman, N. R., Gadwood, R. C. and Shebuski, R. J. (1992) Cromakalim pretreatment reduces infarct size in a rabbit model of regional ischemic-reperfusion injury. J. Mol. Cell. Cardiol. 24: S11.
230. Tranum-Jensen, J., Janse, M. J., Fiolet, J. W. T., Krieger, W. J. G., D'Alnoncourt, C. N. and Durrer, D. (1981) Tissue osmolality, cell swelling, and reperfusion in acute regional myocardial ischemia in the isolated porcine heart. Circ. Res. 49: 364-381.
231. to blockade? J. Cardiovasc. Pharmacol. 18: 445-456.
232. + current, by the diuretic agent indapamide in guinea pig myocytes. Circ. Res. 75: 879-886.
233. University Group Diabetes Program (1970) Diabetes 19 (Suppl.): 747-772.
234. Uprichard, A. C. G. and Lucchesi, B. R. (1989) Failure of glibenclamide to protect against ischemic ventricular fibrillation in a canine model of myocardial infarction. J. Mol. Cell. Cardiol. 21: S89.
235. Uprichard, A. C. G., Chi, L., Driscoll, E. M. and Lucchesi, B. R. (1989) Pinacidil is proarrhythmic in a conscious canine model of sudden death. J. Mol. Cell. Cardiol. 21: S89.
236. Usui, M., Inoue, H., Saihara, S. and Sugimoto, T. (1993) Antifbrillatory effects of class III antiarrhythmic drugs: comparative study with flecainide. J. Cardiovasc. Pharmacol. 21: 376-383.
237. Vandenberg, C. A. (1987) Inward rectification of a potassium channel in cardiac ventricular cells depends on internal magnesium ions. Proc. Natl. Acad. Sci. USA 84: 2560-2564.
238. Vaughan Williams, E. M. (1975) Anti-dysrhythmic drugs - their mode of action. In: Contraction and Relaxation of the Myocardium, pp. 293-323, Nayler, W. G. (ed.) Academic Press, London.
239. Vaughan Williams, E. M. (1984) A classification of antiarrhythmic actions reassessed after a decade of new drugs. J. Clin. Pharmacol. 24: 129-147.
240. + loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle. Circ. Res. 69: 623-637.
241. + loss and cardiac function in ischemic and reperfused mammalian ventricle. Circ. Res. 71: 1324-1333.
242. Vleugels, A., Vereecke, J. and Carmeliet, E. E. (1980) Ionic currents during hypoxia in voltage clamped cat ventricular muscle. Circ. Res. 47: 501-508.
243. Vos, M. A., De Groot, M., Lipcsei, G. E., Leunissen, J. D. and Gorgels, A. P. (1992) Lemakalim demonstrates mechanism specific antiarrhythmic properties without proarrhythmogenicity. Circulation 86: I-560.
244. Wainwright, C. L. (1994) The effects of KATP channel modulators on ischaemic arrhythmias. J. Mol. Cell. Cardiol. 26 (Suppl.): 266.
245. Waldo, A. L., Camm, A. J., de Ruyter, H., Friedman, P. L., MacNeil, D. J., Pitt, B., Schwartz, P. J. and Veltri, E. P. (1995) SWORD Investigators: preliminary mortality results from the survival with oral D-sotalol (SWORD) trial. J. Am. Coll. Cardiol. (Suppl.): 15A.
246. Wallace, A. A., Stupienski, R. F., Brookes, L. M., Selnick, H. G., Claremon, D. A. and Lynch, J. J. (1991) Cardiac electrophysiologic and inotropic actions of new and potent methanesulfonanilide class III antiarrhythmic agents in anesthetised dogs. J. Cardiovasc. Pharmacol. 18: 687-695.
247. Weirich, J., Hohnloser, S. H., Weyerbrock, S. and Antoni, H. (1993) Frequency-dependent effects of dofetilide, a new class III antiarrhythmic agent: significance of slow offset kinetics for its antifibrillatory efficacy. Arch. Pharmacol. 347 (Suppl.): R80.
248. Wenger, T. L., Lederman, S. N. and Strauss, H. C. (1985) Effects of flecainide in dogs with coronary occlusion and reperfusion. Circulation 72: III-225.
249. Wettwer, E., Scholtysik, G., Schaad, A., Himmel, H. and Ravens, U. (1991) Effects of the new class III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters. J. Cardiovasc. Pharmacol. 17: 480-487.
250. Wettwer, E., Grundke, M. and Ravens, U. (1992a) Antiarrhythmic drugs with class III action. Comparative study of E-4031, almokalant and d-sotalol. J. Mol. Cell. Cardiol. 24 (Suppl. 4): S57.
251. Wettwer, E., Grundke, M. and Ravens, U. (1992b) Differential effects of the new class III antiarrhythmic agents almokalant, E-4031 and d-sotalol, and of quninidine, on delayed rectifier currents in guinea pig ventricular myocytes. Cardiovasc. Res. 26: 1145-1152.
252. Wettwer, E., Amos, G., Gath, J., Zerkowski, H.-R., Reidmister, J.-C. and Ravens, U. (1993) Transient outward current in human and rat ventricular myocytes. Cardiovasc. Res. 27: 1662-1669.
253. Wettwer, E., Amos, G., Posival, H. and Ravens, U. (1994) Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circ. Res. 75: 473-482.
254. Wilde, A. A. M. and Janse, M. J. (1994) Electrophysiological effects of ATP sensitive potassium channel modulation: implications for arrhythmogenesis. Cardiovasc. Res. 28: 16-24.
255. Wilde, A. A. M., Escande, D., Schumacher, C. A., Thuringer, D., Mestre, M., Piolet, J. W. T. and Janse, M. J. (1990) Potassium accumulation in the globally ischemic mammalian heart: a role for the ATP-sensitive potassium channel. Circ. Res. 67: 835-843.
256. Winter, S. A., Williams, K. I. and Woodward, B. (1993) Detrimental effect of glibenclamide during ischaemia and reperfusion in the rat isolated heart. Br. J. Pharmacol. 109: 42P.
257. Wolleben, C. D., Sanguinetti, M. C. and Siegl, P. K. S. (1989) Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts. J. Mol. Cell. Cardiol. 21: 783-788.
258. Woosley, R. L. (1991) Antiarrhythmic drugs. Annu. Rev. Pharmacol. Toxicol. 31: 427-455.
259. Wyse, K. R., Ye, V. and Campbell, T. J. (1993) Action potential prolongation exhibits simple dose-dependence for sotalol, but reverse dose-dependence for quinidine and disopyramide: implications for proarrhythmia due to triggered activity. J. Cardiovasc. Pharmacol. 21: 316-322.
260. + current in rat ventricular myocytes. Biophys. J. 68 (Suppl.): A38.
261. + channel. Jpn. J. Pharmacol. 61 (Suppl. 1): 268P.
262. + loss, reduction in repolarization time and tissue ATP levels during myocardial hypoxia and ischemia. Circulation 86: 1-215.
263. Yang, T., Mortensen, E., Bjornstad, H. and Refsum, H. (1990) Class III antiarrhythmic activity of UK-68,798 in acute ischaemic left ventricular failure in dogs. J. Mol. Cell. Cardiol. 22 (Suppl. III): S71.
264. Yang, T., Tande, P. M. and Refsum, H. (1991) Negative chronotropic effect of a novel class III antiarrhythmic drug, UK68,798, devoid of beta-blocking action on isolated guinea pig atria. Br. J. Pharmacol. 103: 1417-1420.
265. Yang, T., Tande, P. M., Lathrop, D. A. and Refsum, H. (1992a) Class III antiarrhythmic action by potassium channel blockade: dofetilide attenuates hypoxia induced electromechanical changes. Cardiovasc. Res. 26: 1109-1115.
266. Yang, T., Tande, P. M., Lathrop, D. A. and Refsum, H. (1992b) Effects of altered extracellular potassium and pacing cycle length on the class III antiarrhythmic actions of dofetilide (UK68,798) in guinea-pig papillary muscle. Cardiovasc. Drugs Ther. 6: 429-436.
267. Yang, T., Tande, P. M. and Refsum, H. (1992c) Electromechanical action of dofetilide and D-sotalol during simulated metabolic acidosis in isolated guinea pig ventricular muscle. J. Cardiovasc. Pharmacol. 20: 889-894.
268. sK protein are enhanced by activators of protein kinase. Proc. Natl. Acad. Sci. USA 91: 1766-1770.
269. Zuanetti, G. and Corr, P. B. (1991) Antiarrhythmic efficacy of a new class III agent, UK-68798, during chronic myocardial infarction: evaluation using three-dimensional mapping. J. Pharmacol. Exp. Ther. 256: 325-34.